AnPac Bio-Medical Science Co Ltd - ADR Stock
AnPac Bio-Medical Science Co Ltd - ADR Stock price
Key metrics
| Market capitalization | $1.67m |
| Enterprise Value | $4.32m |
| EV/Sales (TTM) EV/Sales | 2.54 |
| P/S ratio (TTM) P/S ratio | 0.98 |
| Revenue growth (TTM) Revenue growth | -21.24% |
| Revenue (TTM) Revenue | $1.70m |
| EBIT (operating result TTM) EBIT | $-13.95m |
| Cash position | $70.00k |
| EPS (TTM) EPS | $-42.12 |
Is AnPac Bio-Medical Science Co Ltd - ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
Financial data from AnPac Bio-Medical Science Co Ltd - ADR
| Jun '23 |
+/-
%
|
||
| Revenue | 1.70 1.70 |
21%
21%
|
|
| Gross Profit | 0.85 0.85 |
48%
48%
|
|
| EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | -14 -14 |
7%
7%
|
| Net Profit | -15 -15 |
9%
9%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about AnPac Bio-Medical Science Co Ltd - ADR directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
Anpac Bio-Medical Science Co., Ltd., a development-stage biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests to corporations and life insurance companies in the People's Republic of China and the United States. It also manufactures cancer differentiation analysis devices; and offers physical checkup package services. The company was founded in 2010 and is headquartered in Lishui, the People's Republic of China.
| Head office | Virgin Islands, British |
| CEO | Hao Yu |
| Founded | 2010 |
| Website | www.anpacbio.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
